H04.159
Secondary lacrimal gland atrophy, unspecified lacrimal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary lacrimal gland atrophy refers to the shrinkage or loss of function in the lacrimal glands, which are responsible for producing tears. When these glands atrophy, it can lead to dryness of the eyes and other related issues. This condition may be caused by various underlying illnesses or external factors. Since this is a form of gland atrophy with unspecified details, medical evaluation is recommended for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Chronic inflammation or infections affecting the lacrimal glands Autoimmune diseases such as Sjögren’s syndrome Previous eye surgeries or trauma Radiation therapy near the eye area Age-related gland degeneration Exposure to environmental toxins Underlying systemic diseases
Key Symptoms: Dryness, irritation, or a gritty sensation in the eyes Redness and swelling around the eyes Decreased tear production observed during eye examinations Blurred or fluctuating vision Sensitivity to light and wind Persistent redness or inflammation Unusual discomfort or the sensation of foreign bodies in the eyes
Diagnostic & Treatment
Diagnosis Path: The diagnosis involves a comprehensive eye examination, including testing for tear production, such as the Schirmer’s test. Imaging studies like ultrasound or MRI may be utilized to assess the size and condition of the lacrimal glands. Blood tests can help identify underlying autoimmune or systemic conditions. A detailed medical history is essential to understand potential causes of gland atrophy and to rule out other eye conditions.
Treatment Protocols: Management typically aims to alleviate symptoms and address any underlying causes. This may include the use of artificial tears and lubricating eye drops to reduce discomfort. Treating underlying autoimmune or inflammatory conditions can help slow progression. In some cases, surgical procedures such as lacrimal gland transplantation may be considered. Regular follow-up with an eye specialist is important for monitoring eye health and adapting treatments as needed.
Clinical Advice & FAQs
Billing Guidance
Is H04.159 a billable ICD-10 code?
Yes, H04.159 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H04.159?
Clinical documentation must specify the nature of Secondary lacrimal gland atrophy, unspecified lacrimal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference